Orchid Cellmark last week said that it has appointed William Thomas as vice president and general counsel.
Thomas was formerly senior vice president and general counsel for Cytogen, and was responsible for all legal matters including the management of outside general and intellectual property counsel. Prior to this, Thomas was a senior partner in the law firm of Wilmer Cutler Pickering Hale & Door. He holds a JD from Fordham University School of Law.
SV Life Sciences Advisers, a life-science focused venture capital adviser, said this week that Robert Palmisano has joined the firm as a venture partner.
Palmisano was most recently CEO and director of IntraLase, which was acquired earlier this year by Advanced Medical Optics. He has also served as president, CEO, and a director of Summit Autonomous, a medical products company that was acquired in 2000 by Alcon. Prior to this, Palmisano held various executive positions with Bausch & Lomb.
Lucy Greene has been named associate director for management at the National Institute of Diabetes and Digestive and Kidney Diseases. Greene will serve as the executive officer and will advise the director and other officials on administrative management.
The Detroit Free Press reported last week that the law firm of Miller Canfield announced that Thomas Wootton has joined the firm as senior counsel and Kelly Murphy has joined the firm as an associate. Both are in the intellectual property and life sciences and biotechnology groups in the firm’s Kalamazoo office.